AP-101 is an investigational human-derived antibody that selectively targets the misfolded, toxic form of superoxide dismutase 1 (SOD1) to disrupt the progressive spread of ALS. The goal of this ...

Parent company of Fibe, Social Worth Technologies Ltd, filed for an IPO aiming to raise up to ₹750 crore. Proceeds will ...

It was the Elgin area's first quake in weeks and the fourth in South Carolina over the past 30 days. Only a few people ...

Somewhere among the White House’s fractured fairy tale about its reflecting pool faceplant, the ongoing whodunit masquerading ...

Whether you heat your home with natural gas or oil in the winter, use appliances, drive a gas-powered car, or give it all up ...

Goldman Sachs on Monday raised its price target on Robinhood to $121 from $108 while maintaining a Buy rating, citing record ...

As Europe searches for its next wave of industry 4.0 solutions, the tech startups driving it are increasingly warming up to ...

Glen Parsons collecting ticks behind his home in 2019. First it was for search, but now it's for public awareness.

LONDON — Cellular therapy continues to advance treatment options for severe, refractory autoimmune diseases, according to newly released data presented at the European Alliance of Associations for ...

For an inspiring hour Thursday afternoon, Elm City became BioCity as the New Haven Public Schools (NHPS) graduated 13 high schoolers who have spent the past two years immersed in advanced ...

Maricopa County health officials are alerting the public about a person who had contagious measles at Phoenix Sky Harbor ...

SpaceX’s initial public offering made Elon Musk the world’s first trillionaire. You might think there’s not much you can buy ...